The US Court of Appeals for the Fifth Circuit is reviving PhRMA’s legal attack on Medicare drug price negotiations.
On Friday, the appeals court reversed …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Elion Therapeutics, a biotech focused on invasive fungal infections, has raised $81 million in a Series B funding round for its early-stage candidate, it announced
The TDR Three Key Takeaways for Psychedelics in the Globe and Mail: The Globe and Mail’s articles on psychedelics underline a significant shift towards their
Pathios Therapeutics drew in $25 million for the first close of a Series B raise that should help the UK biotech test its first-in-class solid